• Japanese
  • Korean
  • Chinese
Cover Image

Molecular Imaging Agents: Targets, Technology, Markets and Commercial Opportunities

Driven by advances in molecular probe design and biomarker detection methodologies, new imaging agents that can improve visualization of pathologies and cellular processes are changing the practice of diagnostic medicine. The ability of this new generation of contrast agents to detect metabolic changes at the molecular level has significant potential for improving visualization and quality of care. Targetable and activatable imaging agents are gaining interest for a wide range of diagnostic applications that include cardiology, neurology and soft tissue tumor detection. The number of healthcare conditions that can be effectively imaged noninvasively is expanding as a result of these innovative detection technologies. Targeted and activatable imaging agents offer a unique capability to generate unambiguous images by exploiting specific molecular targets, pathways or cellular processes. This new wave of imaging agents signals a paradigm shift in which the reagents take on new importance.

Highlights

  • Analyzes and assesses emerging imaging diagnostic candidates, their capabilities, benefits, limitations and potential
  • Profiles development-stage imaging agents and examines their clinical status and commercial prospects
  • Analyzes key industry alliances and partnerships by imaging modality, and examines the impact of next-generation imaging candidates on future imaging markets
  • Profiles market participants, their development activity and business strategies
  • Evaluates the impact of economic, technology, and regulatory factors on the development and commercialization of emerging imaging agents

Table of Contents

  • Executive Summary
  • Diagnostic Imaging Market Dynamics
  • The Imaging Agent Landscape
  • Key Application Development Factors
  • Molecular Imaging Agent Marketspace
  • Commercial MIAs
  • Development Stage MIAs
  • Market Drivers
  • Industry Alignment and Competitive Landscape
  • Diagnostic Imaging Product Segment Analysis
  • Imaging Agent Product Segments and Commercial Potential
  • Antibodies
  • Conjugated Radioisotopes
  • Lanthanide Chelates
  • Metabolic Biomarkers
  • Optical Probes
  • Nanoparticles
  • Targeted Imaging Agents
  • Activatable Imaging Agents
  • Leading Academic/Research Programs/Centers
  • MIAs and Imaging Modalities - The Current Picture
  • MRI
  • Optical Imaging
  • PET
  • SPECT
  • Ultrasound
  • Evolution in Imaging Agent Market Segments
  • Disease Detection
  • Image-Guided Drug Delivery
  • Physiological Process Mapping
  • Therapeutic Screening
  • Treatment Assessment
  • Differential Diagnosis
  • MIAs in Healthcare - Clinical Applications
  • Physiological Visualization
  • Angiogenesis
  • Apoptosis
  • Inflammation
  • Neurology
  • Disease Detection and Therapeutic Management
  • Autoimmunity
  • Cardiology
  • Neurology
  • Oncology
  • Market Factors
  • Guidance, Rules and Regulations
  • Managed Care and Reimbursement
  • Academic and Private Sector R&D Programs
  • Alliances & Partnerships
  • Company Profiles
Show More
Pricing
Get Notified
Email me when related reports are published